---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-169309"
form_type: "8-K"
ticker: "VRCA"
cik: "0001660334"
company_name: "Verrica Pharmaceuticals Inc."
filed_at: "2025-07-30T23:59:59+00:00"
generated_at: "2026-05-17T23:05:44.640493+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Verrica receives Nasdaq delisting notice, implements 1-for-10 reverse split to regain bid price compliance

## Summary
- Nasdaq Staff Determination issued July 24, 2025; company may request hearing to stay delisting.
- 1-for-10 reverse stock split effected July 24, 2025 to increase per-share bid price.
- Closing bid price $6.24 on July 29, 2025, above $1.00 minimum for 4 consecutive business days.
- Company will request bid price compliance determination after 10 trading days of compliance.

## SEC filing metadata
- accession: 0001193125-25-169309
- form_type: 8-K
- ticker: VRCA
- cik: 0001660334
- company_name: Verrica Pharmaceuticals Inc.
- filed_at: 2025-07-30T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/0001193125-25-169309-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1660334/000119312525169309/d62269d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-169309
- JSON: https://secwatch.observer/filing/0001193125-25-169309.json
- Plain text: https://secwatch.observer/filing/0001193125-25-169309.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.